Physician profile
Richard C Chu
NPI 1164728044
$45,363.43
in general payments reported to CMS, 2019-2025
30 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $2,641 · 2021: $18K · 2022: $1,695 · 2023: $1,417 · 2024: $1,492 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $6,082 · Travel and Lodging: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,200.00 |
| Food and Beverage | $6,082.12 |
| Travel and Lodging | $215.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $21,747.28 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument, Tearcare System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $10,150.45 | 2019-2021 | |
| Glaukos Corporation | $3,336.23 | 2020-2025 | Idosetr, Kxl System (Not Refurbished), Kxl1b-Ce-Marked Kxlsystem |
| Alcon Vision LLC | $2,837.18 | 2019-2025 | Clareon, Argos, Dailies Total1 |
| Johnson & Johnson Surgical Vision, INC. | $2,596.71 | 2020-2021 | |
| Biotissue Holdings INC. | $1,692.99 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $650.13 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $390.69 | 2022-2025 | Durysta |
| Tarsus Pharmaceuticals, INC. | $361.44 | 2024-2025 | Xdemvy |
| Ocular Therapeutix, INC. | $271.87 | 2025 | Dextenza |
| Alcon Research LLC | $204.48 | 2019-2025 | |
| Allergan, INC. | $188.94 | 2020-2022 | |
| Harrow Eye, LLC | $178.73 | 2024 | Iheezo, Triesence |
| Dompe US, INC. | $124.90 | 2019-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $106.39 | 2019-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $99.25 | 2021 | |
| Rayner Intraocular Lenses Limited | $90.38 | 2024-2025 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Eyepoint US, INC. | $46.26 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $39.84 | 2021 | |
| Eyevance Pharmaceuticals LLC | $38.71 | 2019 | |
| Csl Behring | $36.86 | 2025 | Hizentra |
| Oyster Point Pharma, INC. | $27.29 | 2022 | |
| Horizon Therapeutics Plc | $26.98 | 2023 | Tepezza |
| Rxsight INC | $24.36 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| New World Medical,INC. | $18.29 | 2023 | |
| Thea Pharma INC. | $17.69 | 2023 | |
| Shire North American Group INC | $17.16 | 2019 | |
| Lensar, INC. | $15.94 | 2025 | Lensar Laser System |
| Katena Products, INC. (Dba Corza Medical) | $6.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.